A Phase 1 Study of Intraoperative Administration of CA-008 for the Correction of Hallux Valgus Deformity
Status:
Completed
Trial end date:
2018-04-25
Target enrollment:
Participant gender:
Summary
This is a single-center, randomized, double-blind, placebo-controlled, single ascending dose,
sequential-group Phase 1 study. The study will be conducted utilizing a cohort design, with
sequential groups of 8 subjects. Within each dose cohort, 6 subjects will be randomized to
active, and 2 will be randomized to placebo.